Zinc Lozenges: Epstein Barr, CFS & Mono

[Guest guest]

Zinc Acetate Lozenges: Epstein Barr, CFS & Mononucleosis

 

Continuous use of zinc acetate lozenges while awake as treatment for severe

tonsillitis caused by Epstein Barr virus as mononucleosis in a 17-year old girl

produced rapid

(a) reduction in oral and nasopharyngeal inflammation; (b) elimination of

bilateral shaggy gray tonsillar exudate; © elimination of fever; (d)

improvement in patient's feeling of well-being; (e) elimination of supraorbital

edema; (f) elimination of malaise, and fatigue; (g) return to normal

vocalization; (h) elimination of anorexia; and (i) atrophy of extremely swollen

tonsils to less than normal size. All benefits occurred within 1 to 3 days of

treatment initiation.

 

After the first lozenge, the patient resolutely and continuously used zinc

acetate lozenge treatment, refusing codeine, ibuprofen, and lidocaine.

Corticosteriods for severe airway obstruction were not given in preference to

the beneficial effects reported from zinc acetate lozenges.

 

Antibiotic for concurrent strep throat was continued for the normal course.

Splenomegaly, lymphadenophy, hepatomegaly and other complications did not occur.

No side effects to treatment nor recurrence of diseases occurred. The patient

was able to return to school on the fourth day after diagnosis (which occurred

on the 4th day of illness) and was sufficiently well to resume athletic

activities on the fourteenth day after diagnosis.

 

This anecdote should stimulate others to investigate the antiviral properties of

Zn2+ ion from zinc acetate solutions (1 to 5mmol) against Epstein Barr virus and

to conduct clinical trials of the effects of zinc acetate lozenges in treatment

of mononucleosis.

 

Because zinc acetate releases Zn2+ ions at physiological pH which are antiviral

to several herpes simplex viruses (see Chapter 2 from Handbook for Curing the

Common Cold - The Zinc Lozenge Story), Zn2+ ions also may be antiviral to the

Epstein Barr virus, another member of the herpes family. However a thorough

literature search revealed no evidence of anti-Epstein-Barr activity by Zn2+

ions in 1994.

 

If Zn2+ ions are antiviral to Epstein-Barr viruses, zinc acetate lozenge

treatment of mononucleosis might prevent Burkitt's lymphoma. Burkitt's lymphoma

is associated with Epstein-Barr virus in Africa, Turkey, and other locations

where dietary zinc is often inadequate, but rarely in countries such as the

United States where zinc nutrition is normally adequate. As Burkitt's lymphoma

is a serious and difficult-to-treat disease, immediate investigation of the

effects of zinc acetate lozenges in preventing Burkitt's lymphoma through

treatment of mononucleosis is warranted.

 

Of related interest, Ananda S. Prasad, MD, and others have shown that head and

neck cancer patients with the highest zinc serum concentration have the best

recovery.

 

http://coldcure.com/html/mono.html

_________________

 

JoAnn Guest

mrsjoguest

DietaryTipsForHBP

http://www.geocities.com/mrsjoguest

 

 

 

 

 

 

 

The complete " Whole Body " Health line consists of the " AIM GARDEN TRIO "

Ask About Health Professional Support Series: AIM Barleygreen

 

" Wisdom of the Past, Food of the Future "

 

http://www.geocities.com/mrsjoguest/AIM.html

 

PLEASE READ THIS IMPORTANT DISCLAIMER

We have made every effort to ensure that the information included in these pages

is accurate. However, we make no guarantees nor can we assume any responsibility

for the accuracy, completeness, or usefulness of any information, product, or

process discussed.

 

 

 

 

 

 

 

 

 

Win a $20,000 Career Makeover at HotJobs